François Venter - Concepedia

Author

François Venter

Also Known As

Borrow, Persephone, Chamberlin, Grace, F Venter, F W D Venter, F. Venter, F.W. Venter, F.W.D. Venter, FWD Venter, Francios Venter, Francois D.F. Venter

438

Publications

10.5K

Citations

H-Index

140

Concepts

All Affiliations

University of the Witwatersrand University of Cape Town National Health Laboratory Service University Medical Center Utrecht Perinatal HIV Research Unit

About

François Venter is an author at University of the Witwatersrand specializing in hiv, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	40	2K
2	Health Sciences	6	6	172
3	Nursing	5	5	251
4	Engineering	1	1	12
5	Law	1	1	27

François Venter

149

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV François Venter, Michelle Moorhouse, Simiso Sokhela, New England Journal of Medicine	2019	684
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial François Venter, Simiso Sokhela, Bryony Simmons, The Lancet HIV Week 96Treatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2020	249
Long-COVID: An evolving problem with an extensive impact Marc Mendelson, Jeremy Nel, Lucille Blumberg, South African Medical Journal	2020	246
Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South Africa Rishikesh Dalal, Catherine MacPhail, Mmabatho Mqhayi, JAIDS Journal of Acquired Immune Deficiency Syndromes	2008	194
Adult antiretroviral therapy guidelines 2017 Graeme Meintjes, Michelle Moorhouse, Sergio Carmona, Southern African Journal of HIV Medicine Southern African JournalAntiretroviral TherapyPreventive MedicineHealth PolicyTreatment And Prevention	2017	190
Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study Lesley Scott, Kerrigan McCarthy, Natasha Gous, PLoS Medicine	2011	170
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study Lucas E. Hermans, Michelle Moorhouse, Sergio Carmona, The Lancet Infectious Diseases Antiretroviral TherapyTreatment And PreventionHuman RetrovirusMulticentre Cohort StudyHiv-1 Low-level Viraemia	2017	163
HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project Robyn Eakle, Gabriela B. Gomez, Niven Naicker, PLoS Medicine	2017	159
High Incidence of Unplanned Pregnancy after Antiretroviral Therapy Initiation: Findings from a Prospective Cohort Study in South Africa Sheree Schwartz, Helen Rees, Shruti H. Mehta, PLoS ONE	2012	147
Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa Emily Wong, Tanvier Omar, Gosetsemang J. Setlhako, PLoS ONE	2012	145

Page 1